Changes in glucose tolerance over time in women with polycystic ovary syndrome: A controlled study

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 6, 2005, Pages 3236-3242

  Legro, Richard S ^a   Gnatuk, Carol L ^a   Kunselman, Allen R ^a   Dunaif, Andrea ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; ANDROSTANOLONE; FOLLITROPIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; TIME; WORLD HEALTH ORGANIZATION; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GLUCOSE TOLERANCE TEST; METABOLISM; REFERENCE VALUE;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIHYDROTESTOSTERONE; FEMALE; FOLLICLE STIMULATING HORMONE; GLUCOSE TOLERANCE TEST; HUMANS; LUTEINIZING HORMONE; MENSTRUAL CYCLE; POLYCYSTIC OVARY SYNDROME; REFERENCE VALUES; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TIME FACTORS;

EID: 21244465167     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1843     Document Type: Article

References (39)

1. Zawadski JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome; toward a rational approach. In: Dunaif A, Givens JR, Haseltine F, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific; 377-384
2. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A 1987 Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 65:499-507
3. Legro RS, Kunselman AR, Dodson WC, Dunaif A 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165-169
4. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J 1999 Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141-146
5. Arslanian SA, Lewy VD, Danadian K 2001 Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 86:66-71
6. Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A 2002 Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 87:1017-1023
7. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S 2002 Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346:802-810
8. The DECODE Study Group 1999 Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354:617-621
9. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group 2002 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403
10. Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J; Finnish Diabetes Prevention Study Group 2003 The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26:3230-3236
11. American Diabetes Association 2003 Screening for type 2 diabetes. Diabetes Care 2(Suppl 1):S21-S24
12. ACOG 2002 ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists: number 41, polycystic ovary syndrome. Obstet Gynecol 100:1389-1402
13. The Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
14. Olefsky JM, Reaven GM 1974 Insulin and glucose responses to identical oral glucose tolerance tests performed forty-eight hours apart. Diabetes 23:449-453
15. Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC, Cockram CS 1998 The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem 35:62-67
16. Norman RJ, Masters L, Milner CR, Wang JX, Davies MJ 2001 Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod 16:1995-1998
17. Goodyear LJ, Kahn BB 1998 Exercise, glucose transport, and insulin sensitivity. Ann Rev Med 49:235-261
18. Haffner SM 1996 The insulin resistance syndrome revisited. Diabetes Care 19:275-277
19. Osei K, Cottrell DA, Orabella MM 1991 Insulin sensitivity, glucose effectiveness, and body fat distribution pattern in nondiabetic offspring of patients with NIDDM. Diabetes Care 14:890-896
20. Modan M, Harris MI, Halkin H 1989 Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples. Diabetes 38:1630-1635
21. Lord JM, Flight IH, Norman RJ 2003 Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 327:951-953
22. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T 1992 Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41:1257-1266
23. Legro RS, Finegood D, Dunaif A 1998 A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome J Clin Endocrinol Metab 83:2694-2698
24. Legro RS, Kunselman AR, Dunaif A 2001 Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 111:607-613
25. American Diabetes Association 1997 Clinical practice recommendations Diabetes Care 20(Suppl 1):S1-S70
26. Gutt M, Davis CL, Spitzer SB, Spitzer SB, Llabre MM, Kumar M, Czarnecki EM, Schneiderman N, Skyler JS, Marks JB 2000 Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract 47:177-184
27. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte Jr P 1993 Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672
28. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH 1988 The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319:1500-1506
29. Harris MI 1996 Impaired glucose tolerance-prevalence and conversion to NIDDM. Diabet Med 13:S9-S11
30. Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA 1995 Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes 44:586-591
31. Golland IM, Vaughan Williams CA, Shalet SM, Million LH, Elstein M 1989 Lack of predictive value of HbA1 for impaired glucose tolerance in polycystic ovary syndrome. Gynecol Endocrinol 3:229-235
32. Beks PJ, Mackaay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ 1995 Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia 38:86-96
33. Jackson CA, Yudkin JS, Forrest RD 1992 A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington diabetes survey. Diabetes Res Clin Pract 17:111-123
34. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A 1999 Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22:920-924
35. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470
36. Prelevic GM, Wurzburger MI, Trpkovic D, Balint-Peric L 1990 Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome. Gynecol Endocrinol 4:157-168
37. Cagnacci A, Paoletti AM, Renzi A, Orru M, Pilloni M, Melis GM, Volpe A 2003 Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel. J Clin Endocrinol Metab 88:3621-3625
38. Nader S, Riad-Gabriel MG, Saad MF 1997 The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women. J Clin Endocrinol Metab 82:3074-3077
39. Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Martikainen HK, Tapanainen JS 2000 Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study. J Clin Endocrinol Metab 85:3161-3168